Home › Mycosis Fungoides
Mycosis Fungoides clinical trials recruiting in the U.S.
23 studies for Mycosis Fungoides are recruiting participants at sites across the United States.
Cities with the most studies
- Baldwin Park, CA8 studies
- Houston, TX7 studies
- New York City, NY6 studies
- Mountain View, CA6 studies
- Boston, MA4 studies
- Queens, NY3 studies
- East Norwalk, CT3 studies
- St. Louis, MO3 studies
- Atlanta, GA3 studies
- Tampa, FL3 studies
- Philadelphia, PA3 studies
- Pittsburgh, PA3 studies
- Rochester, MN3 studies
- Scottsdale, AZ3 studies
- Chicago, IL3 studies
By state
- Arizona3 studies
- California11 studies
- Florida3 studies
- Georgia3 studies
- Illinois3 studies
- Massachusetts4 studies
- Minnesota3 studies
- Missouri3 studies
- New Jersey4 studies
- New York7 studies
- Pennsylvania6 studies
- Texas8 studies
Recently updated studies
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07192471A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07003100A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06854653Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04930653A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Aug 24, 2026 · NCT07055477Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT03011814Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 29, 2026 · NCT05357794Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 16, 2026 · NCT06207812Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT06580002Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT06508463Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT04256018Registry of Older Patients With Cancer
RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT03017820A Registry for People With T-cell Lymphoma
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides
RecruitingEarly phase 1
Ages 18 to 90 · All sexes · Updated May 1, 2026 · NCT05838599Photopheresis in Early-stage Mycosis Fungoides
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 27, 2026 · NCT05680558Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT03398161Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT03587844A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 4, 2026 · NCT05296304Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 30, 2025 · NCT00177268Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Oct 27, 2025 · NCT01137643ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
RecruitingObservational study
All ages · All sexes · Updated Oct 22, 2025 · NCT02848274Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2025 · NCT04234048From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.